NeuroFrontiers
Clinical research and advancements furthering clinicians’ ability to diagnose and treat neurological disorders never stop. And neither does NeuroFrontiers, a series dedicated to covering them all. Here neurology specialists will find essential updates on conditions affecting the nervous system, spinal cord, and overall brain health.
So if you want to stay up to date on the latest clinical research and news on neurological disorders, then look no further. Because NeuroFrontiers is where neurology specialists and great minds explore the mind itself.
- Update frequency
- every 3 days
- Episodes
- 369
- Years Active
- 2008 - 2025
TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management
Guest: Jerome A. Barakos, MD
Guest: Danya Khoujah, MBBS, MEHP, FACEP, FAAEM
Guest: B. Joy Snider, MD, PhD
Amyloid-related imaging abnormalities (…
An Overview of ARIA: A Multidisciplinary Crash Course for Baseline Clinical Needs
Guest: Jerome A. Barakos, MD
Guest: Danya Khoujah, MBBS, MEHP, FACEP, FAAEM
Guest: B. Joy Snider, MD, PhD
Guest: Charles P. Vega, MD
Amyloid-…
An Overview of ARIA: A Multidisciplinary Crash Course for Baseline Clinical Needs
Guest: Jerome A. Barakos, MD
Guest: Danya Khoujah, MBBS, MEHP, FACEP, FAAEM
Guest: B. Joy Snider, MD, PhD
Guest: Charles P. Vega, MD
Amyloid-…
Reducing the ALS Diagnostic Delay: The Impacts of a Rapid Access Clinic
ALS can take up to a year to diagnose, but researchers are hard at work trying to find ways to minimize diagnostic delays and errors. One such solution is the R…
Reducing the ALS Diagnostic Delay: The Impacts of a Rapid Access Clinic
ALS can take up to a year to diagnose, but researchers are hard at work trying to find ways to minimize diagnostic delays and errors. One such solution is the R…
Continuum of Care: Managing DMD in Pediatric and Adult Patients
As patients with Duchenne muscular dystrophy (DMD) age, their treatment regimens, considerations, and goals change. That’s why Dr. John Brandsema is here to talk a…
Comprehensive Care: Navigating Neurobehavioral Issues in DMD Patients
Between 60 and 70 percent of patients with Duchenne muscular dystrophy (DMD) also have a diagnosable neurobehavioral phenotype like autism, ADHD, and anxiety. Here…
Comprehensive Care: Navigating Neurobehavioral Issues in DMD Patients
Between 60 and 70 percent of patients with Duchenne muscular dystrophy (DMD) also have a diagnosable neurobehavioral phenotype like autism, ADHD, and anxiety. Here…
Continuum of Care: Managing DMD in Pediatric and Adult Patients
As patients with Duchenne muscular dystrophy (DMD) age, their treatment regimens, considerations, and goals change. That’s why Dr. John Brandsema is here to talk a…
Advances in DMD Care: Evaluating a Gene Therapy’s Efficacy and Safety
Guest: John Brandsema, MD
The gene therapy delandistrogene moxeparvovec was recently approved for patients with Duchenne muscular dystrophy (DMD…
Advances in DMD Care: Evaluating a Gene Therapy’s Efficacy and Safety
Guest: John Brandsema, MD
The gene therapy delandistrogene moxeparvovec was recently approved for patients with Duchenne muscular dystrophy (DMD…
Researching the Overlap: Hepatic Encephalopathy and Dementia in Focus
Guest: Jasmohan Bajaj, MD
Around 50 percent of people with cirrhosis have hepatic encephalopathy, which means some kind of brain dysfunction. As…
Researching the Overlap: Hepatic Encephalopathy and Dementia in Focus
Guest: Jasmohan Bajaj, MD
Around 50 percent of people with cirrhosis have hepatic encephalopathy, which means some kind of brain dysfunction. As…
The Impact of a cholesterol-lowering medication on Alzheimer’s Disease
Guest: Dr. Robert J. Shmookler Reis, PhD
Guest: Dr. Srinivas Ayyadevara, PhD
Numerous factors could predispose patients to the progression o…
The Impact of a cholesterol-lowering medication on Alzheimer’s Disease
Guest: Dr. Robert J. Shmookler Reis, PhD
Guest: Dr. Srinivas Ayyadevara, PhD
Numerous factors could predispose patients to the progression o…
How DDL-920 Could Help Restore Cognitive Function in Alzheimer’s Patients
Guest: Istvan Mody, PhD
The objective of this study around Alzheimer’s disease was to enhance oscillations in laying down memory traces and cognition. Usi…
How DDL-920 Could Help Restore Cognitive Function in Alzheimer’s Patients
Guest: Istvan Mody, PhD
The objective of this study around Alzheimer’s disease was to enhance oscillations in laying down memory traces and cognition. Usi…
Evaluating Endocrine Complications in DMD Patients: Findings from a Survey
Guest: Nadia Merchant, MD
Guest: Melody Shi, MD
Guest: Despoina Galetaki, MD
Steroids are one of the main treatments for patients with D…
Evaluating Endocrine Complications in DMD Patients: Findings from a Survey
Guest: Nadia Merchant, MD
Guest: Melody Shi, MD
Guest: Despoina Galetaki, MD
Steroids are one of the main treatments for patients with D…
The Impact of ECTRIMS Over 40 Years
A special guest will be joining the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 2024 annual meeting on opening day. To learn more ab…